The role of p62/SQSTM1 in sporadic inclusion body myositis

Neuromuscular Disorders

Volumn 27, Issue 4, 2017, Pages 363-369

  Nakano, Satoshi ^a   Oki, Mitsuaki ^b   Kusaka, Hirofumi ^b  

^a OSAKA CITY GENERAL HOSPITAL   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

LC3; Lys63 linked ubiquitin; p62 SQSTM1; Selective autophagy; Sporadic inclusion body myositis (s IBM)

Indexed keywords

LIGHT CHAIN 3 PROTEIN; MEMBRANE PROTEIN; SEQUESTOSOME 1; UBIQUITIN; UNCLASSIFIED DRUG; P62 PROTEIN, HUMAN; RNA BINDING PROTEIN; SQSTM1 PROTEIN, HUMAN;

ADULT; AGED; ARTICLE; AUTOPHAGY; BINDING AFFINITY; BINDING SITE; CELL STRESS; CLINICAL ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DOUBLE COLOR IMMUNOFLUORESCENCE MICROSCOPY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MIDDLE AGED; MOLECULAR PATHOLOGY; MUSCLE BIOPSY; MYOSITIS; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; SPORADIC INCLUSION BODY MYOSITIS; INCLUSION BODY MYOSITIS; METABOLISM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AUTOPHAGY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOSITIS, INCLUSION BODY; RNA-BINDING PROTEINS; SEQUESTOSOME-1 PROTEIN; UBIQUITIN;

EID: 85011012866     PISSN: 09608966     EISSN: 18732364     Source Type: Journal    
DOI: 10.1016/j.nmd.2016.12.009     Document Type: Article

References (39)

1. [1] Mastaglia, F.L., Needham, M., Inclusion body myositis: a review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches. J Clin Neurosci 22 (2015), 6–13.
2. [2] Lahouti, A.H., Amato, A.A., Christopher-Stine, L., Inclusion body myositis: update. Curr Opin Rheumatol 26 (2014), 690–696.
3. [3] Kumamoto, T., Ueyama, H., Tsumura, H., et al. Expression of lysosome-related proteins and genes in the skeletal muscles of inclusion body myositis. Acta Neuropathol 107 (2004), 59–65.
4. [4] Lünemann, J.D., Schmidt, J., Dalakas, M.C., et al. Macroautophagy as a pathomechanism in sporadic inclusion body myositis. Autophagy 3 (2007), 384–386.
5. [5] D'Agostino, C., Nogalska, A., Cacciottolo, M., et al. Abnormalities of NBR1, a novel autophagy-associated protein, in muscle fibers of sporadic inclusion-body myositis. Acta Neuropathol 122 (2011), 627–636.
6. [6] Girolamo, F., Lia, A., Amati, A., et al. Overexpression of autophagic proteins in the skeletal muscle of sporadic inclusion body myositis. Neuropathol Appl Neurobiol 39 (2013), 736–749.
7. [7] Mizushima, N., Yoshimori, T., Ohsumi, Y., The role of Atg proteins in autophagosome formation. Annu Rev Cell Dev Biol 27 (2011), 107–132.
8. [8] Tanida, I., Ueno, T., Kominami, E., LC3 and autophagy. Methods Mol Biol 445 (2008), 77–88.
9. [9] Hiniker, A., Daniels, B.H., Lee, H.S., et al. Comparative utility of LC3, p62 and TDP-43 immunohistochemistry in differentiation of inclusion body myositis from polymyositis and related inflammatory myopathies. Acta Neuropathol Commun, 1, 2013, 29.
10. [10] Nogalska, A., Terracciano, C., D'Agostino, C., et al. p62/SQSTM1 is overexpressed and prominently accumulated in inclusions of sporadic inclusion-body myositis muscle fibers, and can help differentiating it from polymyositis and dermatomyositis. Acta Neuropathol 118 (2009), 407–413.
11. [11] Dubourg, O., Wanschitz, J., Maisonobe, T., et al. Diagnostic value of markers of muscle degeneration in sporadic inclusion body myositis. Acta Myol 30 (2011), 103–108.
12. [12] Brady, S., Squier, W., Sewry, C., et al. A retrospective cohort study identifying the principal pathological features useful in the diagnosis of inclusion body myositis. BMJ Open, 4, 2014, e004552.
13. [13] Moscat, J., Diaz-Meco, M.T., p62 at the crossroads of autophagy, apoptosis, and cancer. Cell 137 (2009), 1001–1004.
14. [14] Kraft, C., Peter, M., Hofmann, K., Selective autophagy: ubiquitin-mediated recognition and beyond. Nat Cell Biol 12 (2010), 836–841.
15. [15] Matsumoto, G., Wada, K., Okuno, M., et al. Serine 403 phosphorylation of p62/SQSTM1 regulates selective autophagic clearance of ubiquitinated proteins. Mol Cell 44 (2011), 279–289.
16. [16] Venkatraman, P., Wetzel, R., Tanaka, M., et al. Eukaryotic proteasomes cannot digest polyglutamine sequences and release them during degradation of polyglutamine-containing proteins. Mol Cell 14 (2004), 95–104.
17. [17] Tan, J.M., Wong, E.S., Kirkpatrick, D.S., et al. Lysine 63-linked ubiquitination promotes the formation and autophagic clearance of protein inclusions associated with neurodegenerative diseases. Hum Mol Genet 17 (2008), 431–439.
18. [18] Wooten, M.W., Geetha, T., Babu, J.R., et al. Essential role of sequestosome 1/p62 in regulating accumulation of Lys63-ubiquitinated proteins. J Biol Chem 283 (2008), 6783–6789.
19. [19] Pankiv, S., Clausen, T.H., Lamark, T., et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J Biol Chem 282 (2007), 24131–24145.
20. [20] Rose, M.R., ENMC IBM Working Group. 188th ENMC International Workshop: inclusion body myositis, 2–4 December 2011, Naarden, The Netherlands. Neuromuscul Disord 23 (2013), 1044–1055.
21. [21] Selcen, D., Engel, A.G., Myofibrillar myopathies. Handb Clin Neurol 101 (2011), 143–154.
22. [22] Panier, S., Durocher, D., Regulatory ubiquitylation in response to DNA double-strand breaks. DNA Repair (Amst) 8 (2009), 436–443.
23. [23] Lauwers, E., Jacob, C., André, B., K63-linked ubiquitin chains as a specific signal for protein sorting into the multivesicular body pathway. J Cell Biol 185 (2009), 493–502.
24. [24] Nishii, M., Nakano, S., Nakamura, S., et al. Myonuclear breakdown in sporadic inclusion body myositis is accompanied by DNA double strand breaks. Neuromuscul Disord 21 (2011), 345–352.
25. [25] El Ayadi, A., Stieren, E.S., Barral, J.M., et al. Ubiquilin-1 regulates amyloid precursor protein maturation and degradation by stimulating K63-linked polyubiquitination of lysine 688. Proc Natl Acad Sci USA 109 (2012), 13416–13421.
26. [26] Askanas, V., Alvarez, R.B., Engel, W.K., Beta-amyloid precursor epitopes in muscle fibers of inclusion body myositis. Ann Neurol 34 (1993), 551–560.
27. [27] Watts, G.D., Wymer, J., Kovach, M.J., et al. Inclusion body myopathy associated with Paget disease of bone and frontotemporal dementia is caused by mutant valosin-containing protein. Nat Genet 36 (2004), 377–381.
28. [28] Shi, Z., Hayashi, Y.K., Mitsuhashi, S., et al. Characterization of the Asian myopathy patients with VCP mutations. Eur J Neurol 19 (2012), 501–509.
29. [29] Ju, J.S., Fuentealba, R.A., Miller, S.E., et al. Valosin-containing protein (VCP) is required for autophagy and is disrupted in VCP disease. J Cell Biol 187 (2009), 875–888.
30. [30] Weihl, C.C., Temiz, P., Miller, S.E., et al. TDP-43 accumulation in inclusion body myopathy muscle suggests a common pathogenic mechanism with frontotemporal dementia. J Neurol Neurosurg Psychiatry 79 (2008), 1186–1189.
31. [31] Salajegheh, M., Pinkus, J.L., Taylor, J.P., et al. Sarcoplasmic redistribution of nuclear TDP-43 in inclusion body myositis. Muscle Nerve 40 (2009), 19–31.
32. [32] Olivé, M., Janué, A., Moreno, D., et al. TAR DNA-binding protein 43 accumulation in protein aggregate myopathies. J Neuropathol Exp Neurol 68 (2009), 262–273.
33. [33] Tresse, E., Salomons, F.A., Vesa, J., et al. VCP/p97 is essential for maturation of ubiquitin-containing autophagosomes and this function is impaired by mutations that cause IBMPFD. Autophagy 6 (2010), 217–227.
34. [34] Larman, H.B., Salajegheh, M., Nazareno, R., et al. Cytosolic 5'-nucleotidase 1A autoimmunity in sporadic inclusion body myositis. Ann Neurol 73 (2013), 408–418.
35. [35] Pluk, H., van Hoeve, B.J., van Dooren, S.H., et al. Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis. Ann Neurol 73 (2013), 397–407.
36. [36] Ipata, P.L., Balestri, F., The functional logic of cytosolic 5'-nucleotidases. Curr Med Chem 20 (2013), 4205–4216.
37. [37] Kulkarni, S.S., Karlsson, H.K., Szekeres, F., et al. Suppression of 5'-nucleotidase enzymes promotes AMP-activated protein kinase (AMPK) phosphorylation and metabolism in human and mouse skeletal muscle. J Biol Chem 286 (2011), 34567–34574.
38. [38] Alers, S., Löffler, A.S., Wesselborg, S., et al. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol 32 (2012), 2–11.
39. [39] Lange, S., Xiang, F., Yakovenko, A., et al. The kinase domain of titin controls muscle gene expression and protein turnover. Science 308 (2005), 1599–1603.